Mohammad Haider Khan and Muhammad Syed Ali Hamza 2026. Resmetirom in fatty liver disease: A promising step ahead in metabolic dysfunction-associated steatotic liver disease treatment. Journal of the Pakistan Medical Association. 76, 06 (May 2026), 1002–1002. DOI:https://doi.org/10.47391/JPMA.32704.